EU's pharmaceutical risk assessment committee puts contraceptive safety concerns to bed
This article was originally published in Scrip
Executive Summary
The risk of venous thromboembolism does not outweigh the benefits of combined oral contraceptives in preventing unwanted pregnancies, the European Medicines Agency's Pharmaceutical Risk Assessment Committee (PRAC) has confirmed.